---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-116951"
form_type: "8-K"
ticker: "RFL"
cik: "0001713863"
company_name: "Rafael Holdings, Inc."
filed_at: "2025-12-02T23:59:59+00:00"
generated_at: "2026-05-16T15:45:21.168665+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Rafael Holdings issues warrants after Cyclo Therapeutics merger; expire Dec 11, 2025

## Summary
- Issued 1,078,796 warrants exercisable for 380,253 Class B shares at $14.19 per share.
- Warrants listed on NYSE American as RFL-WT; expire at 5:00 pm EST on Dec 11, 2025.
- Warrants issued in exchange for Cyclo warrants; each warrant exercisable for ~0.3525 share.
- Cyclo warrants originated from Cyclo's Dec 11, 2020 public offering, adjusted per merger ratio.

## SEC filing metadata
- accession: 0001213900-25-116951
- form_type: 8-K
- ticker: RFL
- cik: 0001713863
- company_name: Rafael Holdings, Inc.
- filed_at: 2025-12-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1713863/000121390025116951/0001213900-25-116951-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1713863/000121390025116951/ea0268072-8k_rafael.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-116951
- JSON: https://secwatch.observer/filing/0001213900-25-116951.json
- Plain text: https://secwatch.observer/filing/0001213900-25-116951.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.